Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1993 of 6351
-
New drug aims to stop the agonizing itch of dialysis
Symptom relief CompletedDouble-blind, Placebo-controlled study to confirm the superiority of MR13A9 to placebo, and followed by extension, open-label treatment to confirm long-term safety of MA13A9 in hemodialysis patients with pruritus.
Phase 3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 15:55 UTC
-
Could zapping a different brain region tame epilepsy?
Disease control CompletedDeep brain stimulation (DBS) is one of the neuromodulation techniques that can be indicated in patients suffering from refractory epilepsies, especially when an open resection has failed or is not indicated, and vagal nerve stimulation (VNS) demonstrated no efficacy. Benefits suc…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug combo aims to outsmart High-Risk leukemia
Disease control Recruiting nowThis phase I trial identifies the best dose and clinical benefit of giving pemigatinib following standard induction chemotherapy in patients with newly diagnosed acute myeloid leukemia. Pemigatinib selectively inhibits FGFR (fibroblast growth factor receptor) activity, a receptor…
Phase 1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Brain stimulation trial targets depression in autistic teens
Symptom relief Recruiting nowThe current clinical trial is focused on evaluating the efficacy of rTMS for treatment of depression in youth and young adults (hereafter called transition aged youth, TAY) with autism spectrum disorder (ASD). The motivation to undertake the current efficacy study is driven by: (…
Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Experimental immune cell therapy shows promise for tough blood cancers
Disease control CompletedThe purpose of the study is to determine the safety of an investigational treatment for myelodysplastic syndrome (MDS) after the first therapy (such as azacitidine or decitabine) stops working or after progression of MDS to acute myeloid leukemia (AML). Funding source - FDA OOPD.
Phase 1/2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Electric pacing device aims to restore breathing and voice in paralyzed larynx patients
Disease control OngoingThe primary purpose of this project is to evaluate the safety of new treatment termed bilateral laryngeal pacing to improve treatment outcomes in patients with bilateral vocal fold paralysis (BVFP) (Aim 1). Outcome measures related to voice and ventilation will also provide initi…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New cocktail targets untreatable liver cancer
Disease control Recruiting nowThis phase I/II trial studies the side effects and how well nivolumab, fluorouracil, and interferon alpha 2b work for the treatment of fibrolamellar cancer (liver cell cancer) that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as nivo…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Experimental combo aims to overcome drug resistance in metastatic cancers
Disease control Recruiting nowThe clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on metastatic pancreatic cancer and metastatic breast cancer. The investigational treatment will involve 2 cycles of a combination of intravenous melphalan, BCNU, vita…
Phase 1 • Sponsor: General Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Brain pacemaker for Tourette's: 5-Year tracking study launches
Disease control Recruiting nowWithin an ongoing deep brain stimulation (DBS) program for Tourette syndrome (TS) at the Department of Neurology, Pitié-Salpêtrière Hospital, Paris/France, the investigator team plans to evaluate patients pre-operatively and then at one year intervals post-operatively until the 5…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Testosterone gel trial aims to beat cancer fatigue in older men
Symptom relief OngoingThis is a large randomized, double-blind, placebo-controlled trial to determine the efficacy of testosterone replacement on cancer-related fatigue in older men with solid or hematologic (blood) cancer who report fatigue and have low testosterone levels.
Phase 2 • Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Can a thymus gland protein shield dialysis patients from COVID-19?
Prevention CompletedThymalfasin (thymosin alpha 1 or Ta1), the active pharmaceutical ingredient in ZADAXIN® injection, is a 28-amino acid synthetic peptide, identical to natural Ta1 produced by the thymus gland. Ta1 is a biological response modifier which activates various cells of the immune system…
Phase 2 • Sponsor: William B. Ershler, MD • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New hope for rare leukemia: targeted pill shows promise in early trial
Disease control OngoingThis is an open-label, nonrandomized phase 2 trial to assess the efficacy of cobimetinib in RAS pathway activated CMML. All eligible patients will be treated daily with cobimetinib in 28-day cycles. Cobimetinib will be administered for three weeks followed by a one week break pr…
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Blood test may unlock targeted cancer drug for more patients
Diagnosis OngoingA new drug, erdafitinib, became available for some patients with bladder cancer that has spread to other organs. To qualify, patients must have specific genetic changes in their tumors. Currently, doctors use tumor tissue samples to check for these genetic changes, but these samp…
Sponsor: Bernie Eigl • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New combo approach cuts heavy drinking and boosts HIV care in fishing communities
Disease control CompletedFisherfolk are a high risk population for HIV and are prioritized to receive antiretroviral treatment (ART) in Uganda, but risky alcohol use among fisherfolk is a barrier to HIV care engagement; multilevel factors influence alcohol use and poor access to HIV care in fishing villa…
Sponsor: San Diego State University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo shows promise in tough brain cancer
Disease control CompletedThis is an open-label, single-center Phase 0/2 study that will enroll up to 30 participants with newly diagnosed (N=12) and recurrent glioblastoma (N=18). The trial will be composed of a Phase 0 component (subdivided into Arm A, Arm B, and Arm C), and an Exploratory Phase 2 compo…
Early phase 1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Surgery before standard treatment may extend life in cervical cancer
Disease control Recruiting nowThis is an national, prospective, multicenter and randomized clinical study designed to determine if patients with stage IIICr of cervical cancer have longer PFS and/or OS with lymph node dissection before CCRT when compared to CCRT.
Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:34 UTC
-
New drug shows promise for chronic itch in Long-Term trial
Symptom relief OngoingThe primary purpose of this study is to assess the long-term safety of nemolizumab (CD14152) in participants with prurigo nodularis (PN).
Phase 3 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Retraining your gait: a new hope for knee osteoarthritis?
Symptom relief CompletedThis pilot study aims to assess the effect of a 6-week individualized gait retraining program on knee load and symptoms in persons with knee osteoarthritis (OA).
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Prenatal education may stop common virus that harms babies
Prevention CompletedThis study will evaluate whether a brief prenatal clinic-based cytomegalovirus (CMV) risk-reduction behavioral intervention will prevent maternal CMV infections during pregnancy in women.
Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Could a 2-Hour online class before hip surgery boost recovery?
Symptom relief CompletedOsteoarthritis (OA), leading to hip replacement, is a leading contributor to global mobility impairment. Given the boom in the older demographic it is not surprising that there is an 11% increased demand for replacement every 5 years in Canada. Health promotion interventions, suc…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC